M Smahel Selected Research

chlorobromofosfamide

11/2001

Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Smahel Research Topics

Disease

4	Neoplasms (Cancer) 01/2007 - 03/2001
3	Carcinoma (Carcinomatosis) 11/2001 - 01/2000
1	Autoimmune Diseases (Autoimmune Disease) 09/2002
1	Hypersensitivity (Allergy) 09/2002
1	Sarcoma (Soft Tissue Sarcoma) 11/2001
1	Residual Neoplasm 01/2000
1	Neoplasm Metastasis (Metastasis) 01/2000

Drug/Important Bio-Agent (IBA)

2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2007 - 11/2001
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 01/2000
2	DNA VaccinesIBA 01/2007 - 09/2002
2	VaccinesIBA 03/2001 - 12/2000
1	Histocompatibility Antigens Class IIBA 01/2007
1	GlucuronidaseIBA 01/2007
1	chlorobromofosfamideIBA 11/2001
1	Ifosfamide FDA LinkGeneric 11/2001
1	Oncogene Proteins (Oncogene Protein)IBA 03/2001
1	AntigensIBA 03/2001
1	Interleukin-2 (IL2)IBA 01/2000
1	Interleukin-12 (IL 12)IBA 01/2000
1	CytokinesIBA 01/2000

Therapy/Procedure

2	Therapeutics 11/2001 - 01/2000
1	Immunotherapy 01/2007
1	Injections 01/2007
1	Drug Therapy (Chemotherapy) 11/2001
1	Transplantation 01/2000